Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01928589 · ClinicalTrials.gov registry record · NA
Partial Irradiation and Sequential vs. Concurrent Chemo Early Breast Cancer
A NA study of Breast Cancer and Adenocarcinoma of the Breast, sponsored by Richard Zellars.
- Active
- Registry status
- NA
- Development phase
- 81
- Enrollment target
- 10
- Study locations
NCT01928589 is a NA study of Breast Cancer and Adenocarcinoma of the Breast that is active but no longer recruiting, run by Richard Zellars. The registered enrollment target is 81 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (97% lower). The trial reports 10 study locations across 5 states.
The verdict
NCT01928589, a NA study of Breast Cancer and Adenocarcinoma of the Breast, is active but no longer recruiting, sponsored by Richard Zellars.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 81 participants
- Enrollment target
- 10
- Study locations
Study Summary
In a small study at Johns Hopkins, women were treated with partial breast irradiation and chemotherapy given at the same time. We are now testing in a bigger study whether giving partial breast irradiation and chemotherapy at the same time (our new method) has the same side effects and outcomes as giving partial breast irradiation and chemotherapy at different times(older method). In this study women who had their breast cancer removed but need radiation to the breast will be randomized to partial breast irradiation at the same time as chemotherapy or partial breast radiation at a different time than chemotherapy. Randomization is like flipping a coin but in this study about 2 of every 3 women will get the new method.
Conditions Studied
Interventions
- OTHER PBI with sequential chemotherapy
- OTHER PBI with concurrent chemotherapy
Study Locations (10)
Indiana
- Parkview Regional Medical Center - Fort Wayne
- Indiana University Health Hospital - Indianapolis
- Indiana University Health Melvin and Bren Simon Comprehensive Cancer Center - Indianapolis
- IU Health Arnett - Lafayette
Maryland
- John Hopkins University - Baltimore
- Suburban Hospital - Bethesda
Pennsylvania
- Reading Hospital - West Reading
- York Cancer Center - York
District of Columbia
- Sibley Memorial Hospital - Washington D.C.
Texas
- University of Texas-San Antonio - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2014-01-16 |
| Est. Completion | 2028-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01928589
The ClinicalTrials.gov registry entry for NCT01928589 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (97% lower). The listed sponsor is Richard Zellars, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which PBI with sequential chemotherapy is the first listed.
NCT01928589 reports 10 study locations spanning 5 distinct geographic areas - top geographies include Indiana, Maryland, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01928589 about?
NCT01928589 is a clinical study titled "Partial Irradiation and Sequential vs. Concurrent Chemo Early Breast Cancer". In a small study at Johns Hopkins, women were treated with partial breast irradiation and chemotherapy given at the same time. We are now testing in a bigger study whether giving partial breast irradiation and chemotherapy at the same time (our new method) has the same side effects and outcomes as ...
What is the current status of trial NCT01928589?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 81 participants. The study started on 2014-01-16. Estimated completion is 2028-12.
What conditions does trial NCT01928589 study?
This clinical trial studies the following conditions: Breast Cancer, Adenocarcinoma of the Breast.
What interventions are being tested in trial NCT01928589?
The interventions under investigation include: PBI with sequential chemotherapy (OTHER), PBI with concurrent chemotherapy (OTHER).
Who is sponsoring clinical trial NCT01928589?
This trial is sponsored by Richard Zellars, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01928589 being conducted?
This trial has 10 study locations across District of Columbia, Indiana, Maryland, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Explore more on PlainTrial
Breast Cancer
All registered trials for this condition
Adenocarcinoma of the Breast
All registered trials for this condition
District of Columbia
All trials with a study site in District of Columbia
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.